Impact of dietary Na+ on glycyrrhetinic acid-like factors (kidney 11β-(HSD2)-GALFs) in human essential hypertension

被引:22
作者
Morris, DJ
Lo, YH
Lichtfield, WR
Williams, GH
机构
[1] Brown Univ, Miriam Hosp, Sch Med, Dept Pathol & Lab Med, Providence, RI 02906 USA
[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
licorice; 11 beta-hydroxysteroid dehydrogenase; glycyrrhetinic acid; glycyrrhetinic acid-like factors; hypertension;
D O I
10.1161/01.HYP.31.1.469
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Our previous studies have shown that human urine contains glycyrrhetinic acid-like factors (GALFs) that possess inhibitory activity against kidney 11 beta-hydroxysteroid dehydrogenase isoform 2 (HSD2). The present studies were undertaken to determine the impact of dietary Na+ intake on the levels of kidney 11 beta(HSD2)-GALFs. The excretion of kidney 11 beta(HSD2)-GALFs in 24-hour urine samples of 30 unmedicated subjects (10 normotensive and 10 high/normal-renin and 10 low-renin essential hypertensive subjects) on both 200- and 10-mmol Na+ diets was studied, No differences in the urinary levels of kidney 11 beta(HSD2)-GALFs were observed among the three groups on the high-Na+ diet. However, with a low-Na+ diet, the levels of kidney 11 beta(HSD2)-GALFs were significantly increased in. hypertensive subjects but not in normal subjects, Levels increased from 8.3+/-1.4 to 17.3+/-2.9 and 6.7+/-1.3 to 10.6+/-1.4 carbenoxolone sodium units/d in high/normal-renin (P=.01) and low-renin hypertensive subjects (P=.07), respectively; normal subjects changed from 8.0+/-1.9 to 10.6+/-2.4, The levels of kidney 11 beta(HSD2)-GALFs were significantly higher in the high/normal-renin hypertensive subjects than in either the control normotensive subjects or the low-renin hypertensive subjects when challenged with the low-Na+ diet (P<.05 by Wilcoxon rank-sum test), The greater response of the high/normal-renin essential hypertensive subjects indicated that they may utilize kidney 11 beta(HSD2)-GALFs when challenged with a low-Na+ diet, whereas the low-renin essential hypertensive subjects do not.
引用
收藏
页码:469 / 472
页数:4
相关论文
共 21 条
  • [1] AGARWAL AK, 1994, J BIOL CHEM, V269, P25959
  • [2] CLONING AND TISSUE DISTRIBUTION OF THE HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2 ENZYME
    ALBISTON, AL
    OBEYESEKERE, VR
    SMITH, RE
    KROZOWSKI, ZS
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1994, 105 (02) : R11 - R17
  • [3] CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR
    ARRIZA, JL
    WEINBERGER, C
    CERELLI, G
    GLASER, TM
    HANDELIN, BL
    HOUSMAN, DE
    EVANS, RM
    [J]. SCIENCE, 1987, 237 (4812) : 268 - 275
  • [4] 11 beta OH-progesterone affects vascular glucocorticoid metabolism and contractile response
    Brem, AS
    Bina, RB
    King, T
    Morris, DJ
    [J]. HYPERTENSION, 1997, 30 (03) : 449 - 454
  • [5] BIDIRECTIONAL ACTIVITY OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN VASCULAR SMOOTH-MUSCLE CELLS
    BREM, AS
    BINA, RB
    KING, T
    MORRIS, DJ
    [J]. STEROIDS, 1995, 60 (05) : 406 - 410
  • [6] LOCALIZATION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR
    EDWARDS, CRW
    BURT, D
    MCINTYRE, MA
    DEKLOET, ER
    STEWART, PM
    BRETT, L
    SUTANTO, WS
    MONDER, C
    [J]. LANCET, 1988, 2 (8618) : 986 - 989
  • [7] MINERALOCORTICOID ACTION - TARGET TISSUE-SPECIFICITY IS ENZYME, NOT RECEPTOR, MEDIATED
    FUNDER, JW
    PEARCE, PT
    SMITH, R
    SMITH, AI
    [J]. SCIENCE, 1988, 242 (4878) : 583 - 585
  • [8] Kidney 11 beta-HSD2 is inhibited by glycyrrhetinic acid-like factors in human urine
    Lo, YH
    Sheff, MF
    Latif, SA
    Ribeiro, C
    Silver, H
    Brem, AS
    Morris, DJ
    [J]. HYPERTENSION, 1997, 29 (01) : 500 - 505
  • [9] THE SYNDROME OF APPARENT MINERALOCORTICOID EXCESS - ITS ASSOCIATION WITH 11 BETA-DEHYDROGENASE AND 5 BETA-REDUCTASE DEFICIENCY AND SOME CONSEQUENCES FOR CORTICOSTEROID METABOLISM
    MONDER, C
    SHACKLETON, CHL
    BRADLOW, HL
    NEW, MI
    STONER, E
    IOHAN, F
    LAKSHMI, V
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (03) : 550 - 557
  • [10] 11-BETA-HYDROXYSTEROID DEHYDROGENASE
    MONDER, C
    WHITE, PC
    [J]. VITAMINS AND HORMONES, VOL 47: ADVANCES IN RESEARCH AND APPLICATIONS, 1993, 47 : 187 - 271